- Parisi, R.; Iskandar, I.Y.K.; Kontopantelis, E.; Augustin, M.; Griffiths, C.E.M.; Ashcroft, D.M. (2020). National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study. BMJ. 369:m1590. doi: 10.1136/bmj.m1590.
- Ramessur, R.; Corbett, M.; Marshall, D.; Acencio, M.L.; Barbosa, I.A.; Dand, N.; Di Meglio, P.; Haddad, S.; Jensen, A.H.M.; Koopmann, W.; Mahil, S.K.; Ostaszewski, M.; Rahmatulla, S.; Rastrick, J.; Saklatvala, J.; Weidinger, S.; Wright, K.; Eyerich, K.; Ndlovu, M.; Barker, J.N.; Skov, L.; Conrad, C.; Smith, C.H. (2022). Biomarkers of disease progression in people with psoriasis: a scoping review. British Journal of Dermatology. 187(4): 481-493. doi.org/ 10.1111/ bjd.21627.
- Ford, A.R.; Siegel, M.; Bagel, J.; Cordoro, K.M.; Garg, A.; Gottlieb, A. (2018). Dietary Recommendations for Adults with Psoriasis or Psoriatic Arthritis From the Medical Board of the National Psoriasis Foundation: A Systematic Review. JAMA Dermatol [Internet]. 154(8):934-950.
- Papp, K.A.; Lebwohl, M.G.; Kircik, L.; Pariser, D.; Strober, B.; Krueger, G.; Higham, R.C. (2021). The PASI-HD improved precision in measuring disease severity in subjects with mild to moderate plaque psoriasis treated with roflumilast cream, a phosphodiesterase-4 inhibitor. Journal of the American Academy of Dermatology. 85(3): AB164.
- Capon, F. (2017). The genetic basis of psoriasis. International journal of molecular sciences. 18(12): 25-26.
- Elnabawi, Y.A.; Dey, A.K.; Goyal, A.; Groenendyk, J.W.; Chung, J.H.; Belur, A.D.; Mehta, N. N. (2019). Coronary artery plaque characteristics and treatment with biologic therapy in severe psoriasis: results from a prospective observational study. Cardiovascular research. 115(4): 721-728.
- Sirin, M.C.; Korkmaz, S.; Erturan, I.; Filiz, B.; Aridogan, B.C.; Cetin, E.S.; Yildirim, M. (2020). Evaluation of monocyte to HDL cholesterol ratio and other inflammatory markers in patients with Psoriasis. Anais brasileiros de dermatologia. 95: 575-582. doi.org/ 10.53350 /pjmhs22164940.
- Mora, S. (2016). Nonfasting for routine lipid testing: From evidence to action. JAMA Intern Med. 176 (7): 1005–1006.
- Anderson, L.N.; Maguire, J.L.; Lebovic, G.; Hanley, A.J.; Hamilton, J.; Adeli, K. (2017). Duration of fasting, serum lipids, and metabolic profile in early childhood. The Journal of Pediatrics. 180: 47–52.
- Raj, D.M.; Ravi, K.; Sankar, S. A. (2017). study on preanalytical errors in EDTA blood collected for cell counting. J Evol Med Dent Sci. 6(22): 1788-1794.
- Sundstrom, K.; Lamin, H.; Dillner, J. (2021). Validation of the cobas 6800 (e411) human papillomavirus test in primary cervical screening. PLoS One. 16(2): e247291. doi: 10.1371/journal.pone.0247291.
- Brazzelli, V.; Maffioli, P.; Bolcato, V.; Ciolfi, C.; D'Angelo, A.; Tinelli, C.; Derosa, G. (2021). Psoriasis and diabetes, a dangerous association: evaluation of insulin resistance, lipid abnormalities, and cardiovascular risk biomarkers. Frontiers in Medicine. 8: 605-610.
- Lea, W.A.; Cornish, H.H.; Block W.D. (1958). Studies on serum lipids, proteins, and lipoproteins in psoriasis. J Invest Dermatol. 30(4):181–185.
- Coban, M.; Tasli, L.; Turgut, S.; Özkan, S.; Ata, M.T.; Akin, F. (2016). Association of adipokines, insulin resistance, hypertension and dyslipidemia in patients with psoriasis vulgaris. Annals of dermatology. 28(1): 74-79. doi.org/10.5021/ad. 2016. 28. 1.74.
- Corbetta, S.; Angioni, R.; Cattaneo, A.; Beck-Peccoz, P.; Spada, A. (2006). Effects of retinoid therapy on insulin sensitivity, lipid profile and circulating adipocytokines. Eur J Endocrinol. 154(1):83-86. doi: 10.1530/eje.1.02057.PMID: 16381995.
- Nowowiejska, J.; Baran, A.; Flisiak, I. (2023). Lipid Alterations and Metabolism Disturbances in Selected Inflammatory Skin Diseases. Int J Mol Sci. 24(8):7053. doi: 10.3390/ijms24087053.
- Pietrzak, A.; Lecewicz-Toruń, B.; Kadziela-Wypyska, G. (1998). Changes in the digestive system in patients suffering from psoriasis. Ann Univ Mariae Curie Sklodowska Med. 53:187–194.
- Sachdev, S.S.; Jamil, A.; Gunabalasingam, P.; Safdar, N.A. (2022). The Effects of Acitretin on Insulin Resistance, Glucose Metabolism, and Lipid Levels in Patients with Psoriasis. Indian J Dermatol. 67(4): 349-354. doi: 10.4103/ijd.ijd-328-21.
- Castro, K.R.; Aikawa, N.E.; Saad, C.G. (2011). Infliximab induces increase in triglyceride levels in psoriatic arthritis patients. Clin Dev Immunol. 2011:352686.
- Mallbris, L.; Granath, F.; Hamsten, A.; Stahle, M. (2006). Psoriasis is associated with lipid abnormalities at the onset of skin disease. J Am Acad Dermatol. 54(4):614–621.
- Piskin, S.; Gurkok, F.; Ekuklu, G.; Senol, M. (2003). Serum lipid levels in psoriasis. Yonsei Med J. 44(1):24–26.
|